The future of cytology looks promising with advancements in technology and molecular biology. Techniques like liquid biopsy, which analyzes circulating tumor cells in blood, are emerging as powerful tools for non-invasive cancer diagnosis and monitoring. Additionally, the integration of artificial intelligence in cytological analysis is expected to enhance diagnostic accuracy and efficiency.
